Compare · ELV vs FTRE
ELV vs FTRE
Side-by-side comparison of Elevance Health Inc. (ELV) and Fortrea Holdings Inc. (FTRE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and FTRE operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $85.74B, about 58.2x FTRE ($1.47B).
- Over the past year, ELV is up 6.2% and FTRE is up 209.2% - FTRE leads by 203.0 points.
- FTRE has been more active in the news (13 items in the past 4 weeks vs 8 for ELV).
- FTRE has more recent analyst coverage (25 ratings vs 23 for ELV).
PerformanceELV+6.25%FTRE+209.20%
2025-06-23+0.00%2026-06-23
- Company
- Elevance Health Inc.
- Fortrea Holdings Inc.
- Price
- $395.62+0.19%
- $15.80+1.61%
- Market cap
- $85.74B
- $1.47B
- 1M return
- +1.55%
- +20.15%
- 1Y return
- +6.25%
- +209.20%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 8
- 13
- Recent ratings
- 23
- 25
ELV
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest ELV
- Elevance Health Makes Clinical Review Faster, More Connected with Health OS
- SEC Form 11-K filed by Elevance Health Inc.
- SEC Form 11-K filed by Elevance Health Inc.
- Elevance Health Announces $640 Million Investment in Affordable Housing Over the Past Five Years, Surpassing $1 Billion in Total Commitment Nationwide
- CAO & Controller Penczek Ronald W sold $148,766 worth of shares (369 units at $403.16), decreasing direct ownership by 9% to 3,740 units (SEC Form 4)
- Elevance Health Makes Chronic Care Easier to Navigate With Connected, Personalized Support
- Director Dixon Robert L Jr sold $60,667 worth of shares (151 units at $401.77), decreasing direct ownership by 1% to 10,734 units (SEC Form 4)
- Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
- CAO & Controller Penczek Ronald W exercised 1,531 shares at a strike of $294.30 and sold $617,192 worth of shares (1,531 units at $403.13) (SEC Form 4)
Latest FTRE
- Director Sanders Machelle converted options into 38,817 shares, increasing direct ownership by 533% to 46,099 units (SEC Form 4)
- Director Smith David Ross converted options into 38,817 shares and covered exercise/tax liability with 18,244 shares, increasing direct ownership by 216% to 30,117 units (SEC Form 4) (tax liability)
- Director Pesicka Edward A converted options into 38,817 shares, increasing direct ownership by 285% to 52,453 units (SEC Form 4)
- SEC Form 4 filed by Director Neupert Peter M
- Chief Operating Officer Morais Mark A. sold $78,617 worth of shares (4,674 units at $16.82), decreasing direct ownership by 6% to 71,365 units (SEC Form 4)
- Director Ray Amrit converted options into 38,817 shares, increasing direct ownership by 285% to 52,453 units (SEC Form 4)
- SEC Form 4 filed by Director Sharbaugh William J
- Director Russell Erin L converted options into 38,817 shares, increasing direct ownership by 115% to 72,617 units (SEC Form 4)
- Fortrea Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)